Affiliation:
1. Department of Oral and Maxillofacial Surgery Nagoya University Graduate School of Medicine Nagoya Japan
2. Department of Pathology and Biological Responses Nagoya University Graduate School of Medicine Nagoya Japan
3. Center for Low‐Temperature Plasma Sciences Nagoya University Nagoya Japan
4. Division of Molecular and Cellular Biology Kobe University Graduate School of Medicine Kobe Japan
Abstract
AbstractObjectiveThis study aimed to investigate the effect of plasma‐activated Ringer's lactate solution (PAL) on oral squamous cell carcinoma (OSCC) cells and carcinogenic processes with a particular focus on iron and collagenous matrix formation.Materials and MethodsWe used three OSCC cell lines, one keratinocyte cell line, and two fibroblast lines, and cell viability assays, immunoblotting, flow cytometry, and transmission electron microscopy were performed to evaluate the effect and type of cell death. The effect of PAL treatment on lysyl oxidase (LOX) expression was investigated in vitro and in vivo. Tamoxifen‐inducible Mob1a/b double‐knockout mice were used for the in vivo experiment.ResultsPAL killed OSCC cells more effectively than the control nontumorous cells and suppressed cell migration and invasion. Ferroptosis occurred and the protein level of LOX was downregulated in cancer cells in vitro and in vivo. Additionally, PAL improved the survival rate of mice and suppressed collagenous matrix formation.ConclusionsWe demonstrated that PAL specifically kills OSCC cells and that ferroptosis occurs in vitro and in vivo. Furthermore, PAL can prevent carcinogenesis and improve the survival rate of oral cancer, especially tongue cancer, by changing collagenous matrix formation via LOX suppression.
Funder
Japan Society for the Promotion of Science
Subject
General Dentistry,Otorhinolaryngology
Reference41 articles.
1. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK
2. Ferroptosis: An emerging therapeutic target for oral cancer
3. The rationale for targeting the LOX family in cancer
4. Cancer of the oral cavity and pharynx (invasive). (1975–2017).Trends in SEER Incidenceab and U.S. Mortalityc using the joinpoint regression program (1975–2017) with up to five joinpoints 2000–2017 with up to three joinpoints both sexes by race.Ethnicity.https://seer.cancer.gov/archive/csr/1975_2017/results_merged/sect_20_oral_cavity_pharynx.pdf
5. Lysyl Hydroxylase 2 Is Secreted by Tumor Cells and Can Modify Collagen in the Extracellular Space